Targeting malignant tumors with high precision is challenging for biomedical researchers. However, this scenario is likely to witness a paradigm shift in the near future, through the use of specially engineered bacteria, that can eliminate malignant cells efficiently.
Imperial spinout wins £1.6m Innovate UK grant for NK cell therapies – Pharmaceutical Technology
The grant will cover the manufacturing development of therapies by NK:IO in collaboration with the Cell and Gene Therapy Catapult. Credit: crystal light via Shutterstock. Innovate
July 12, 2023